Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Invesco Biotechnology & Genome ETF PBE

Full chart Compare
Set alert

Price alert · PBE

All alert types
102.34 USD +1.21 (+1.20%)

Nov 3, 2026, 3:59 PM EST

102.34 Day range 103.15
73.16 52-week range 104.24
YTD
+24.58%
1 year
+37.02%

Invesco Biotechnology & Genome ETF

Issuer
Invesco
Asset class
Equity
Expense ratio
0.59%
Assets under management
$435.33M
NAV
101.00
Holdings
31
Inception
2005-06-23
Top 10 weight
49.37%

Top holdings

  1. REGN Regeneron Pharmaceuticals Inc 5.63%
  2. GILD Gilead Sciences Inc 5.59%
  3. BIIB Biogen Inc 5.50%
  4. NTRA Natera Inc 5.49%
  5. RPRX Royalty Pharma PLC 5.23%
  6. AMGN Amgen Inc 5.14%
  7. ILMN Illumina Inc 4.91%
  8. VRTX Vertex Pharmaceuticals Inc 4.88%
  9. MRNA Moderna Inc 3.70%
  10. EXEL Exelixis Inc 3.29%
  11. HALO Halozyme Therapeutics Inc 3.14%
  12. QGEN QIAGEN NV 3.07%
  13. UTHR United Therapeutics Corp 3.06%
  14. VCYT Veracyte Inc 2.96%
  15. TGTX TG Therapeutics Inc 2.88%
  16. NVAX Novavax Inc 2.69%
  17. LEGN Legend Biotech Corp 2.64%
  18. SRPT Sarepta Therapeutics Inc 2.58%
  19. RGEN Repligen Corp 2.53%
  20. NBIX Neurocrine Biosciences Inc 2.52%
  21. VCEL Vericel Corp 2.49%
  22. PTGX Protagonist Therapeutics Inc 2.46%
  23. INCY Incyte Corp 2.46%
  24. BMRN BioMarin Pharmaceutical Inc 2.31%
  25. COLL Collegium Pharmaceutical Inc 2.29%

Sector weights

  • Healthcare 99.96%
  • Financial Services 0.04%
  • Cash & Others 0.00%

Country weights

  • United States 100.00%

Updated 2026-11-03

Held by funds

2 US ETFs and mutual funds hold PBE · largest positions

Funds holding PBE, by value held
FundValue heldWeight in fund
DALT $1.50M2.90%
TIH $242.71K0.04%